KardiaMobile® 6L vs 12-lead ECG Impact on Clinic Time
A Wiley study explored KardiaMobile 6L’s ability to shorten ECG collection time compared to a standard 12-lead ECG without compromising data usability.
Composed of 100 patients, the study showed that approximately 3 minutes of room utilization time was saved with KardiaMobile 6L compared to the 12-lead, representing a 30% reduction in ECG acquisition time.
Formal integration of KardiaMobile 6L into clinic workflow would likely also cut down on further utilization time. If supported by larger randomized trials, KardiaMobile 6L should be considered for ECG collection when rhythm and intervals are the main priority.
Key Takeaways:
- The average time saved for room utilization time with KardiaMobile 6L is substantial and could help with patient satisfaction, physician satisfaction, and appropriate prescriptions
- KardiaMobile 6L proved an infrequent need for an additional 12-lead ECG
- KardiaMobile 6L can be particularly useful in areas where a 12-lead ECG is not readily available and demonstrates more robust room utilization time in settings with less experienced MAs
Clinical Evidence
Handheld 6-Lead Validated for QT Monitoring
JAMAnetwork.com | A 6-lead device transforms cardiac care in resource-limited settings. This study in JAMA highlights its accuracy in monitoring QT intervals, reducing standard 12-lead ECG dependency, and easing access to cardiac care.
Remote Monitoring in Decentralized Trials
JAMAnetwork.com | Patient-centric trials require accessible digital health technologies. A JAMA study explores the current state and aspired role of remote monitoring and data collection tools in oncology trials.
KardiaMobile® 6L vs 12-lead ECG Impact on Clinic Time
Wiley.com | Clinic utilization time is significantly reduced with the KardiaMobile® 6L compared to traditional 12-lead ECG systems. This study published in Wiley highlights how KardiaMobile 6L minimizes the need for frequent conventional 12-lead use.